CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Perrigo

perrigo

Perrigo Updates Note Offer

Perrigo Co. (NYSE: PRGO) announced that, in connection with its offer to purchase for cash its 2.950% Notes due 2023, it has received the requisite consents to amend the indenture governing the notes.

WWJ Newsradio 950–11/21/2013

perrigologo

Perrigo Confirms Filing For Generic Version Of Acanya

The Allegan generic drugmaker and store brand health products producer Perrigo Co. (NYSE: PRGO) Wednesday announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for Clindamycin Phosphate and Benzoyl Peroxide Gel 1.2%/2.5% and has notified Dow Pharmasciences, the owner of the New Drug Application, of its filing.

WWJ Newsradio 950–11/20/2013

perrigo

Perrigo Shareholders Approve Elan Acquisiton

The generic prescription drug and store-brand health products maker Perrigo Co. (NYSE: PRGO) announced that its shareholders approved proposals related to its acuqisition of Ireland’s Elan Corp. plc at a special meeting Monday.

WWJ Newsradio 950–11/18/2013

perrigologo

Perrigo Announces FDA Final Approval For Generic Version Of Nitrolingual Spray

Perrigo Co. (NYSE: PRGO) announced that it has received final approval for its abbreviated new drug application for nitroglycerin lingual spray, 400 mcg/spray, the generic equivalent to Nitrolingual Pumpspray.

WWJ Newsradio 950–09/23/2013

perrigo

Perrigo Sets Records For Quarterly, Annual Sales, Profits

The Allegan health and beauty products maker Perrigo Co. (Nasdaq: PRGO) reported record sales and net income for the fourth fiscal quarter and fiscal year ended June 29.

WWJ Newsradio 950–08/15/2013

perrigo

Perrigo Launching Three New Products

The Allegan generic drug maker will begin making two oils for dermatitis and a cancer drug.

WWJ Newsradio 950–08/12/2013

perrigo

Perrigo Sponsors Infant Nutrition Educational Initiative

The health and beauty products maker Perrigo Co. (NYSE: PRGO) announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of Pediatrics to increase educational awareness around infant nutrition, health, and feeding options.

WWJ Newsradio 950–08/05/2013

perrigologo

Perrigo Announces FDA Final Approval For Generic Equivalent To Cutivate Lotion

Perrigo Co. (NYSE: PRGO) Wednesday announced that it has received final approval for its abbreviated new drug application for fluticasone propionate lotion, 0.05%, the generic equivalent to Cutivate Lotion, 0.05%.

WWJ Newsradio 950–07/31/2013

perrigo

Perrigo Acquires Irish Competitor, Will Become Irish Company

The Allegan generic and store-brand health products maker Perrigo Co. announced early Monday that it would acquire Dublin, Ireland-based Elan Corp. plc for $8.6 billion (5.6 billion pounds).

WWJ Newsradio 950–07/29/2013

perrigo

Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XR

Perrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.

WWJ Newsradio 950–05/29/2013

more